GlaxoSmithKline, Europe’s largest drugmaker, named 43-year-old Briton Andrew Witty as its new chief executive. Witty takes the helm from Frenchman Jean-Pierre Garnier next May. “He has the luxury of time, since he could be there for the best part of 20 years,” said analyst Peter Cartwright at Evolution Securities. (Reuters)
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Home Depots are the new epicenters of ICE raidsIn the Spotlight The chain has not provided many comments on the ongoing raids
-
Why does Trump keep interfering in the NYC mayoral race?Today's Big Question The president has seemingly taken an outsized interest in his hometown elections, but are his efforts to block Zohran Mamdani about political expediency or something deeper?
-
The pros and cons of banning cellphones in classroomsPros and cons The devices could be major distractions
